Human radiation dosimetry of 6-[{sup 18}F]FDG predicted from preclinical studies
- Department of Radiology, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio 44106 (United States)
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio 44106 and Case Center for Imaging Research, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio 44106 (United States)
- Department of Medicine, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio 44106 (United States)
Purpose: The authors are developing 6-[{sup 18}F]fluoro-6-deoxy-D-glucose (6-[{sup 18}F]FDG) as an in vivo tracer of glucose transport. While 6-[{sup 18}F]FDG has the same radionuclide half-life as 2-[{sup 18}F]fluoro-2-deoxy-D-glucose (2-[{sup 18}F]FDG) which is ubiquitously used for PET imaging, 6-[{sup 18}F]FDG has special biologic properties and different biodistributions that make it preferable to 2-[{sup 18}F]FDG for assessing glucose transport. In preparation for 6-[{sup 18}F]FDG use in human PET scanning, the authors would like to determine the amount of 6-[{sup 18}F]FDG to inject while maintaining radiation doses in a safe range. Methods: Rats were injected with 6-[{sup 18}F]FDG, euthanized at specified times, and tissues were collected and assayed for activity content. For each tissue sample, the percent of injected dose per gram was calculated and extrapolated to that for humans in order to construct predicted time-courses. Residence times were calculated as areas under the curves and were used as inputs to OLINDA/EXM in order to calculate the radiation doses. Results: Unlike with 2-[{sup 18}F]FDG for which the urinary bladder wall receives the highest absorbed dose due to urinary excretion, with 6-[{sup 18}F]FDG there is little urinary excretion and osteogenic cells and the liver are predicted to receive the highest absorbed doses: 0.027 mGy/MBq (0.100 rad/mCi) and 0.018 mGy/MBq (0.066 rad/mCi), respectively. Also, the effective dose from 6-[{sup 18}F]FDG, i.e., 0.013 mSv/MBq (0.046 rem/mCi), is predicted to be approximately 30% lower than that from 2-[{sup 18}F]FDG. Conclusions: 6-[{sup 18}F]FDG will be safe for use in the PET scanning of humans.
- OSTI ID:
- 22250968
- Journal Information:
- Medical Physics, Journal Name: Medical Physics Journal Issue: 3 Vol. 41; ISSN 0094-2405; ISSN MPHYA6
- Country of Publication:
- United States
- Language:
- English
Similar Records
Radiation dose to the bladder wall from 2-( sup 18 F)fluoro-2-deoxy-D-glucose in adult humans
Radiation-induced DNA damage and the relative biological effectiveness of 18F-FDG in wild-type mice
Estimated radiation dose to the newborn in FDG-PET studies
Journal Article
·
Sun Mar 31 23:00:00 EST 1991
· Journal of Nuclear Medicine; (USA)
·
OSTI ID:5643501
Radiation-induced DNA damage and the relative biological effectiveness of 18F-FDG in wild-type mice
Journal Article
·
Tue May 27 20:00:00 EDT 2014
· Mutagenesis
·
OSTI ID:1196276
Estimated radiation dose to the newborn in FDG-PET studies
Journal Article
·
Wed Jan 31 23:00:00 EST 1996
· Journal of Nuclear Medicine
·
OSTI ID:381135